Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIRECT: Doxycycline Adjunctive Therapy for Central Nervous System Tuberculosis
NCT06446245Phase 2Recruiting
- Sponsor
- National University Hospital
- Start
- Aug 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of doxycycline in central nervous system tuberculosis (CNS-TB), sponsored by National University Hospital. Started Aug 2025; status: recruiting.
02
Drugs
doxycycline
03
Conditions
central nervous system tuberculosis (CNS-TB)
Beyond the preview
Go deeper on NCT06446245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446245.